Indian Journal of Animal Research

  • Chief EditorK.M.L. Pathak

  • Print ISSN 0367-6722

  • Online ISSN 0976-0555

  • NAAS Rating 6.50

  • SJR 0.263

  • Impact Factor 0.5 (2023)

Frequency :
Monthly (January, February, March, April, May, June, July, August, September, October, November and December)
Indexing Services :
Science Citation Index Expanded, BIOSIS Preview, ISI Citation Index, Biological Abstracts, Scopus, AGRICOLA, Google Scholar, CrossRef, CAB Abstracting Journals, Chemical Abstracts, Indian Science Abstracts, EBSCO Indexing Services, Index Copernicus
Indian Journal of Animal Research, volume 52 issue 1 (january 2018) : 173-174

Comparative efficacy of cryoprotectant in the lyophilization of pigeon paramyxovirus-1 vaccine

Mousam Das, Devi Prasad Isore, Chanchal Guha, Ujjwal Biswas, Amaresh Chatterjee
1<p>Department of Veterinary Microbiology, West Bengal University of Animal &amp;Fishery Sciences,&nbsp;37, K. B. Sarani, Kolkata- 700037, West Bengal, India.</p>
Cite article:- Das Mousam, Isore Prasad Devi, Guha Chanchal, Biswas Ujjwal, Chatterjee Amaresh (2017). Comparative efficacy of cryoprotectant in the lyophilizationof pigeon paramyxovirus-1 vaccine . Indian Journal of Animal Research. 52(1): 173-174. doi: 10.18805/ijar.v0iOF.7656.

Preparation of live attenuated freeze dried Pigeon Paramyxo Virus-1 (PPMV-1) vaccine selection of proper cryoprotectant which could preserve and protect the virus against injury due to reduction of temperature at the time of lyophilization, was very necessary. PPMV-1 locally isolated lentogenic strain was selected as seed virus which was properly attenuated by serially passaging in 9 to 10 days old embryonated specific pathogen free (SPF) fowl eggs and produced master seed virus and working seed virus. Five per cent lactalbumin hydrolysate with 10% sucrose (LAS) and 1% polyvinyl pyrrolidone (PVP) were used as two different cryoprotectant for lyophilization of working seed virus. After lyophilization value of haemagglutination (HA) titer and embryo infective dose fifty per ml (EID50/ml) were changed and concluded that both LAS and PVP could be used as suitable cryoprotectant where LAS was better than PVP which was first time done in the whole world.

  1. Adams, G. (2007). The principles of freeze drying. In: Cryopreservation and freeze drying protocols, (Day, J.G. and Stacey, G.N), 2nd Ed., Human press, Totowa, New Jersey, pp 15-38.

  2. Asim, M., Rashid, A. and Chaudhary A.H. (2008). Effect of various stabilizers on titre of lyophilized liveattenuated peste des petits ruminants (ppr) vaccine. Pak. Vet. J., 28: 203-204.

  3. Corbanie, E.A., Remon, J.P., van Reeth, K., Landman, W.J.M., van Eck, J.H.H. and Vervaet, C. (2007). Spray drying of an attenuated live Newcastle disease vaccine virus intended for respiratory mass vaccination of poultry. Vaccine, 25: 8306–8317.

  4. Mikhael, C.A. (2013). Comparative efficacy of various chemical protectants on the thermostability of pigeon pox vaccine. Suez Canal Vet. Med. J., 18: 111-123.

  5. OIE (2012). World Organisation for Animal Health (OIE). (2012). Newcastle Disease. In: OIE Terrestrial Manual 2012, nationale des Epizooties, Paris, France.

  6. OIE (2015). World Organisation for Animal Health (OIE). (2015). Rinderpest. In: OIE Terrestrial Manual 2015, Office Internationale des Epizooties, Paris, France, pp 9.

  7. Pegg, D.E. (2007). Principles of Cryopreservation. In: Cryopreservation and freeze drying protocols, 2nd Ed., [Day, J.G. and Stacey, G.N.], Human press, Totowa, New Jersey, pp 39-58.

  8. Pisal, S., Wawde, G., Salvankar, S., Lade, S. and Kadam, S. (2006). Vacuum foam drying for preservation of LaSota virus: Effect of additives. AAPS Pharm. Sci. Tech., 7: 30-37.

  9. Reed, L.J. and Muench, L.H. (1938). A simple method of estimating fifty per cent end points. Am. J. Hygeine, 27: 493-497.

  10. Sarkar, J., Sreenivasa, B.P., Singh, R.P., Dhar, P. and Bandyopadhyay, S.K. (2003). Comparative efficacy of various chemical stabilizers on the thermostability of a live-attenuated peste des petits ruminants (PPR) vaccine. Vaccine, 21: 4728-4735.

Editorial Board

View all (0)